Answer Summary

Members shared mixed experiences with Mounjaro, a diabetes injection increasingly used off-label for weight loss, with some reporting... Read more

Members shared mixed experiences with Mounjaro, a diabetes injection increasingly used off-label for weight loss, with some reporting significant weight loss (10-25 pounds) but many struggling with persistent nausea, vomiting, and insurance denials since most plans only cover it for diabetic patients. Several members expressed concern that the medication should be prioritized for diabetics who genuinely need it, noting shortages and access issues, while others warned about severe side effects including one member's daughter being hospitalized in ICU for uncontrollable vomiting. A recurring theme was frustration over medication-induced weight gain from RA treatments, the difficulty exercising with joint limitations, insurance barriers to weight management support, and concerns about regaining weight once stopping the injections.